Familial Hypercholesterolemia Market Size and Share
Familial hypercholesterolaemia (FH), is an autosomal dominant genetic disorder being characterized by the severe hypercholesterolaemia along with cholesterol deposits in tendons and premature heart disease. FH further classified into two homozygous and heterozygous forms.
This specific ailment is caused by mutation in the gene for the LDL cholesterol receptor, which is involved in passing LDL from the body. It has also been observed that, the mutations in some other genes such as PCSK9 and Apolipoprotein B gene can also cause inherited high cholesterol as these all three genes are connected with each other. It is also worth mentioning here that the probability of getting affected with FH is increased due to the inheritance of a specific type of mutation in any of these three genes.
Familial Hypercholesterolemia Market Size and Share
-
The estimated overall US prevalence of probable/definite FH was 0.40% or 1 in 250. FH prevalence in the US is varied by age, being least common in 20 to 29-year-olds and most common in 60 to 69-year-olds.[Sarah D. de Ferranti et al. (2016)]
-
The lowest incident population of FH was recorded in Japan (in 7MM)
-
The United States has the highest percentage of incident diagnosed & treated patients in 7MM
-
Spain has consistently shown lowest diagnosed & treated population among EU5 Countries
-
Among the FH patients, females show a higher proportion of incidence of FH as compared to males in the 7MM
Familial Hypercholesterolemia Market
DelveInsight’s “Familial Hypercholesterolemia Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Familial Hypercholesterolemia, historical and forecasted epidemiology as well as the Familial Hypercholesterolemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Key Benefits of Familial Hypercholesterolemia Market Report
-
Familial Hypercholesterolemia market report provides an in-depth analysis of Familial Hypercholesterolemia Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
-
The Familial Hypercholesterolemia market report will help in developing business strategies by understanding the Familial Hypercholesterolemia Market trends & developments, key players and future market competition that will shape and drive the Familial Hypercholesterolemia market in the upcoming years.
-
The Familial Hypercholesterolemia market report covers Familial Hypercholesterolemia current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
-
The report provides a detailed assessment of the Familial Hypercholesterolemia market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
For more details visit:
https://www.delveinsight.com/report-store/Familial%20Hypercholesterolemia%20-%20Market%20Insight